• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1800094 达格列净片 dapagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2018-08-15 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-11-12 view
JXHS1900077 达格列净片 dapagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2019-06-10 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-06-24 view
JYHB1700825 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2017-06-19 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-11-21 view
JXHL1500158 达格列净片 dapagliflozin Tablet Chemical Drugs Import Drug Application 2015-07-10 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-03-23 view
JYHB1901166 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2019-10-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-12-19 view
JYHB1701259 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2017-09-29 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2017-10-03 view
JXHS1500113 达格列净片 dapagliflozin Tablet Chemical Drugs Import Drug Application 2015-12-16 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-03-20 view
JYHB2001112 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2020-06-30 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-07-01 view
JYHB1801042 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2018-08-31 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-09-05 view
JXHL1700010 达格列净片 dapagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2017-02-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-06-27 view
JYHB1800328 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2018-03-22 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-06-12 view
JXHS1900076 达格列净片 dapagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2019-06-10 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2020-06-24 view
JYHB1700827 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2017-06-08 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-10-20 view
JYHB1900890 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2019-07-26 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-12-26 view
JYHB1701015 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2017-08-08 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-11-19 view
JYHB2001113 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2020-06-30 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2020-07-01 view
JYHB1801041 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2018-08-31 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Filed 2018-09-05 view
JXHL1700009 达格列净片 dapagliflozin Tablet Chemical Drugs(2.4) Import Drug Application 2017-02-06 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2017-06-27 view
JYHB1900717 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2019-06-22 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2019-09-16 view
JYHB1700960 达格列净片 dapagliflozin Tablet Chemical Drugs Supplementary Application 2017-07-19 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2018-11-09 view